" /> Acalabrutinib Maleate - CISMeF





Preferred Label : Acalabrutinib Maleate;

NCIt synonyms : Acalabrutinib Maleate Anhydrous;

NCIt definition : The maleate form of acalabrutinib, an orally available inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. Upon administration, acalabrutinib inhibits the activity of BTK and prevents the activation of the B-cell antigen receptor (BCR) signaling pathway. This prevents both B-cell activation and BTK-mediated activation of downstream survival pathways. This leads to an inhibition of the growth of malignant B cells that overexpress BTK. BTK, a member of the src-related BTK/Tec family of cytoplasmic tyrosine kinases, is overexpressed in B-cell malignancies; it plays an important role in B lymphocyte development, activation, signaling, proliferation and survival.;

UNII : LV51EK7IGP;

InChIKey : JWEQLWMZHJSMEC-AFJTUFCWSA-N;

CAS number : 2242394-65-4;

NCI Metathesaurus CUI : CL1412174;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
15/08/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.